Clinical meaning
Acetaminophen (paracetamol, Tylenol) is one of the most commonly used over-the-counter analgesics and antipyretics worldwide, and acetaminophen overdose is the leading cause of acute liver failure in North America. At therapeutic doses (maximum 4 grams per day in healthy adults, 2 grams per day in patients with liver disease), approximately 90% of acetaminophen is metabolized in the liver through glucuronidation and sulfation (phase II conjugation reactions), producing non-toxic metabolites excreted by the kidneys. Approximately 5-10% is oxidized by the cytochrome P450 enzyme system (primarily CYP2E1) into a highly reactive toxic intermediate called N-acetyl-p-benzoquinone imine (NAPQI). Under normal circumstances, NAPQI is immediately detoxified by conjugation with glutathione (an endogenous antioxidant) to form non-toxic mercapturic acid and cysteine conjugates. In overdose situations, the glucuronidation and sulfation pathways become saturated, shunting a larger proportion of acetaminophen through the CYP2E1 pathway. This generates massive amounts of NAPQI that overwhelm the available glutathione stores. When glutathione is depleted below approximately 30% of normal levels, free NAPQI accumulates and binds covalently to hepatocyte proteins and mitochondrial structures, causing oxidative stress, mitochondrial dysfunction, and hepatocellular necrosis. The damage predominantly affects zone 3 (centrilobular region) of the hepatic acinus because CYP2E1 concentration is highest in this area. Hepatocellular necrosis releases intracellular enzymes (AST, ALT) into the bloodstream, with levels potentially exceeding 10,000 IU/L in severe cases. Progressive liver destruction impairs synthetic function (decreased albumin, decreased clotting factors causing coagulopathy with elevated INR/PT), conjugation function (rising bilirubin causing jaundice), and detoxification function (ammonia accumulation causing hepatic encephalopathy). The Rumack-Matthew nomogram is a clinical tool that plots serum acetaminophen concentration against time since ingestion (starting at 4 hours post-ingestion) to determine the risk of hepatotoxicity and the need for N-acetylcysteine (NAC) treatment. NAC works by replenishing glutathione stores, providing an alternative substrate for NAPQI conjugation, and enhancing the non-toxic sulfation and glucuronidation metabolic pathways. NAC is most effective when administered within 8 hours of ingestion but may still provide benefit up to 72 hours post-ingestion.